Nutex Health Inc.
NUTX Healthcare Medical Care Facilities
Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow NUTX
Nutex Health Inc. (NUTX) Altman Z-score
Nutex Health Inc.'s Altman Z-score for fiscal 2025 is 3.27, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 3.27 | 2.19 |
| FY2024 | 1.09 | 1.85 |
| FY2023 | −0.76 | 0.58 |
| FY2022 | −1.33 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.41 | — | 0.50 | |
| Retained earnings / total assets | (0.31) | — | −0.44 | |
| EBIT / total assets | 0.30 | — | 0.99 | |
| Market value of equity / total liabilities | 2.12 | — | 1.27 | |
| Sales / total assets | 0.95 | — | 0.95 | |
| Altman Z-score | Safe zone | 3.27 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 4.62 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| HCSG Healthcare Services Group, Inc. compare | 6.6× |
| INNV InnovAge Holding Corp. compare | 4.6× |
| NUTX Nutex Health Inc. | 3.3× |
| PNTG The Pennant Group, Inc. compare | 2.3× |
| AMN AMN Healthcare Services Inc compare | 2.3× |
| USPH U.S. Physical Therapy, Inc. compare | 2.1× |
| ARDT Ardent Health, Inc. compare | 2.0× |
| AGL Agilon Health, Inc. compare | 1.5× |
| CMPS COMPASS Pathways PLC Sponsored ADR compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets